The system utilized DM1 patient-derived MYOD-inducible, immortalized fibroblasts containing a CLCN1-luciferase mini-gene construct to monitor the DM1 CLCN1 intron 2 retention defect [77,78]. This evidence concerns the gene CLCN1 and myotonic dystrophy type 1.